|
🐜
|
French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002
26 auth.
D. Descamps,
M. Chaix,
P. André,
V. Brodard,
J. Cottalorda,
C. Deveau,
M. Harzic,
D. Ingrand,
J. Izopet,
E. Kohli,
B. Masquelier,
Said Mouajjah,
P. Palmer,
I. Pellegrin,
J. Plantier,
...
C. Poggi,
S. Rogez,
A. Ruffault,
V. Schneider,
Anne Signori-Schmück,
C. Tamalet,
M. Wirden,
C. Rouzioux,
F. Brun-vezinet,
L. Meyer,
D. Costagliola
|
7 |
2005 |
7
🐜
|
|
🐬
|
Effects of a combination of zidovudine, didanosine, and lamivudine on primary human immunodeficiency virus type 1 infection.
A. Lafeuillade,
C. Poggi,
C. Tamalet,
N. Profizi,
C. Tourrès,
O. Costes
|
6 |
1997 |
6
🐬
|
|
🐜
|
Hepatitis E virus in HIV-infected patients
10 auth.
C. Renou,
A. Lafeuillade,
J. Cadranel,
N. Pavio,
A. Pariente,
T. Allègre,
...
C. Poggi,
G. Pénaranda,
F. Cordier,
É. Nicand
|
6 |
2010 |
6
🐜
|
|
🐜
|
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021
107 auth.
A. Gaymard,
P. Bosetti,
Adeline Feri,
G. Destras,
V. Enouf,
A. Andronico,
S. Burrel,
S. Behillil,
C. Sauvage,
A. Bal,
F. Morfin,
S. van der Werf,
L. Josset,
F. Blanquart,
B. Coignard,
...
S. Cauchemez,
B. Lina,
E. Gault,
F. Moreau,
S. Brichler,
H. Delagreverie,
D. Descamps,
C. Charpentier,
F. Rozenberg,
A. L’Honneur,
D. Veyer,
L. Bélec,
S. Fourati,
C. Rodriguez,
J. Pawlotsky,
J. Fourgeaud,
Hanène Abid,
A. Roque-Afonso,
H. Fenaux,
A. Jary,
S. Marot,
M. Salmona,
M. Chaix,
L. Morand‐Joubert,
A. Schnuriger,
Stéphanie Marque Juillet,
Pauline Bargain,
C. Poggi,
L. Chollet,
C. Guillaume,
J. Guinard,
S. Vallet,
L. Pilorgé,
E. Schvoerer,
C. Hartard,
S. Castelain,
C. François,
A. Ducancelle,
C. Lefeuvre,
Q. Lepiller,
S. Marty-Quinternet,
P. Bellecave,
C. Tumiotto,
J. Dina,
M. Le Gouil,
C. Henquell,
A. Mirand,
R. Césaire,
A. de Rougemont,
C. Auvray,
S. Larrat,
B. Némoz,
C. Tinez,
A. Guigon,
S. Hantz,
S. Rogez,
G. Dos Santos,
P. Perez,
Christelle Jost,
B. Montes,
V. Foulongne,
B. Imbert,
C. Bressollette,
V. Giordanengo,
G. Gonfrier,
Magali Garcia,
N. Lévêque,
V. Brodard,
H. Moret,
V. Thibault,
A. Maillard,
M. Jaffar-Bandjee,
M. Gueudin,
J. Plantier,
B. Pozzetto,
S. Pillet,
S. Fafi-Kremer,
Morgane Solis,
J. Izopet,
P. Trémeaux,
K. Stéfic,
L. Handala,
G. Billaud,
É. Frobert,
A. Mérens,
C. Bigaillon,
M. Desroches,
C. Thépenier,
F. Janvier,
M. Otto,
B. Roquebert,
S. Haïm-Boukobza
|
6 |
2021 |
6
🐜
|
|
🐢
|
Residual human immunodeficiency virus type 1 RNA in lymphoid tissue of patients with sustained plasma RNA of <200 copies/mL.
A. Lafeuillade,
L. Chollet,
G. Hittinger,
N. Profizi,
O. Costes,
C. Poggi
|
6 |
1998 |
6
🐢
|
|
🐬
|
Quantification of HIV‐1 viral load in lymphoid and blood cells: assessment during four‐drug combination therapy
C. Tamalet,
A. Lafeuillade,
J. Fantini,
C. Poggi,
N. Yahi
|
5 |
1997 |
5
🐬
|
|
🐬
|
Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma.
A. Lafeuillade,
C. Poggi,
N. Profizi,
C. Tamalet,
O. Costes
|
5 |
1996 |
5
🐬
|
|
🐬
|
Predictors of plasma human immunodeficiency virus type 1 RNA control after discontinuation of highly active antiretroviral therapy initiated at acute infection combined with structured treatment interruptions and immune-based therapies.
A. Lafeuillade,
C. Poggi,
G. Hittinger,
E. Counillon,
D. Émilie
|
5 |
2003 |
5
🐬
|
|
🐜
|
Pilot Study of a Combination of Highly Active Antiretroviral Therapy and Cytokines to Induce HIV‐1 Remission
7 auth.
A. Lafeuillade,
C. Poggi,
S. Chadapaud,
G. Hittinger,
M. Chouraqui,
M. Pisapia,
...
E. Delbeke
|
5 |
2001 |
5
🐜
|
